Temenos Group (OTCMKTS:TMSNY – Get Free Report)’s stock price traded down 4.8% during mid-day trading on Thursday . The company traded as low as $80.80 and last traded at $80.80. 201 shares were traded during trading, a decline of 90% from the average session volume of 1,925 shares. The stock had previously closed at $84.87.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the company. Barclays raised Temenos Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 4th. Citigroup raised Temenos Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 14th. Finally, Berenberg Bank raised Temenos Group to a “hold” rating in a report on Friday, March 20th. Two equities research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy”.
Check Out Our Latest Stock Report on Temenos Group
Temenos Group Price Performance
About Temenos Group
Temenos Group is a leading provider of banking software systems, specializing in core banking platforms and digital front‐end solutions for financial institutions worldwide. The company’s flagship product, Temenos Transact, delivers end‐to‐end core banking functionality, enabling banks to manage accounts, deposits, loans and payments on a unified platform. Complementing this offering, Temenos Infinity provides digital banking capabilities, including online and mobile channels, customer onboarding, relationship management and analytics tools designed to enhance customer engagement and operational efficiency.
Founded in Geneva in 1993, Temenos serves more than 3,000 financial institutions across over 150 countries, ranging from community banks and credit unions to global systemically important banks.
See Also
- Five stocks we like better than Temenos Group
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
- Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
- Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress
Receive News & Ratings for Temenos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Temenos Group and related companies with MarketBeat.com's FREE daily email newsletter.
